A discussion between Steve Gurney from Positive Aging Community and two leaders in cognitive health, Dr. Doug Elwood, Chief Medical Officer at Sunday Health, and Dr. Emer MacSweeney, founder and CEO of Recognition Health. The conversation highlights an innovative partnership aimed at improving access to cognitive care and early detection of neurodegenerative diseases, particularly Alzheimer's. Sunday Health offers modern cognitive care practices, focusing on early identification and preventive care, while Recognition Health provides advanced diagnostic services and access to clinical trials for new medications.  

The collaboration enables seamless patient referrals for clinical trials and treatments, emphasizing the importance of early diagnosis and intervention. The discussion also covers the evolving landscape of Alzheimer's treatments, including new medications that target amyloid protein in the brain, and the significance of modifiable risk factors in cognitive health. The speakers stress the urgency of early detection and treatment, likening the approach to managing chronic conditions like diabetes and cardiovascular disease. The partnership aims to revolutionize cognitive care by providing timely access to cutting-edge treatments and comprehensive support for patients. 

More details at 

• https://www.sundayhealth.org/ 
• https://www.recognitionhealthusa.com/